Takeda Pharmaceutical Company Limited et al v. Actavis Laboratories FL, Inc. et al
| Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals America, Inc. and Orexigen Therapeutics, Inc. |
| Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Andrx Corporation and Actavis, Inc. |
| 1:2015cv00451 |
| June 3, 2015 |
| US District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Richard G. Andrews |
| Patent |
| 35 U.S.C. § 271 |
| None |
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
|
|
|
|
|
|
|
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.